Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Khanna, Ashwani K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL; GAMMA INTERFERON; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P21; PROTEIN P22; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HEME OXYGENASE 1; HMOX1 PROTEIN, MOUSE; LIPID; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; KNOCKOUT MOUSE; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ANIMAL FOOD; BIOSYNTHESIS; CELL PROLIFERATION; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOUSE MUTANT; TIME;

ANIMALIA; MUS;

ANIMAL FEED; ANIMALS; ANTIGENS, CD36; AORTA; ATHEROSCLEROSIS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; LIPIDS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NADPH OXIDASE; RNA, MESSENGER; TIME FACTORS;

EID: 68949104261     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-66     Document Type: Article

References (59)

1. Atherosclerosis - an inflammatory disease. R Ross, N Engl J Med 1999 340 115 126
2. Changing concepts of atherogenesis. P Libby, J Intern Med 2000 247 349 358
3. Regulation of immune mechanisms in atherosclerosis. GK Hansson, Ann N Y Acad Sci 2001 947 157 165 11795263
4. Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application. GJ Blake PM Ridker, Ital Heart J 2001 2 796 800 11770860
5. Concerted effect of transforming growth factor-beta, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation. A Khanna, Am J Physiol Heart Circ Physiol 2004 286 H1133 1140
6. TGF-betas and TGF-beta receptors in atherosclerosis. TA McCaffrey, Cytokine Growth Factor Rev 2000 11 103 114
7. A pivotal role for TGF-beta in atherogenesis? DJ Grainger JC Metcalfe, Biol Rev Camb Philos Soc 1995 70 571 596
8. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. DJ Grainger, Arterioscler Thromb Vasc Biol 2004 24 399 404
9. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. A Bobik A Agrotis P Kanellakis R Dilley A Krushinsky V Smirnov E Tararak M Condron G Kostolias, Circulation 1999 99 2883 91 10359732
10. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. KD O'Brien KL Olin CE Alpers W Chiu M Ferguson K Hudkins TN Wight A Chait, Circulation 1998 98 519 527
11. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and proximity of platelet-derived growth factor and transforming growth factor-β SP Evanko EW Raines R Ross LI Gold TN Wight, Am J Pathol 1998 152 533 546 9466580
12. Genomic instability in the type II TGF- 1 receptor gene in atherosclerotic and restenotic vascular cells. TA McCaffrey B Du S Consigli P Szabo PJ Bray L Hartner BB Weksler TA Sanborn G Bergman HL Bush Jr, J Clin Invest 1997 100 2182 2188
13. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor- 1 via increased expression of urokinase and the urokinase receptor. DJ Falcone TA McCaffrey J Mathew K McAdam W Borth, J Cell Physiol 1995 164 334 343
14. Increased expression of transforming growth factor-1 as a stabilizing factor in human atherosclerotic plaques. F Cipollone M Fazia G Mincione A Iezzi B Pini C Cuccurullo S Ucchino F Spigonardo M Di Nisio F Cuccerullo A Mezzetti E Porreca, Stroke 2004 35 2253 2257
15. and Cyclosporine induces the expression of the cyclin inhibitor p21. A Khanna J Hosenpud, Transplantation 1999 67 1262 1268
16. Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathway. M Sata A Takahashi K Tanaka M Washida N Ishizaka J Ako M Yoshizumi Y Ouchi T Taniguchi Y Hirata M Yokoyama R Nagai K Walsh, Arterioscler Thromb Vasc Biol 2002 22 1305 1309
17. TGF-beta1 down regulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. G Draude RL Lorenz, Am J Physiol Heart Circ Physiol 2000 278 H1042 1048 10749696
18. Heme oxygenase-1 protects against vascular constriction and proliferation. HJ Duckers M Boehm AL True SF Yet H San JL Park R Clinton Webb ME Lee GJ Nabel EG Nabel, Nat Med 2001 7 693 698
19. Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells. HO Pae GS Jeong SO Jeong HS Kim SA Kim YC Kim SJ Yoo HD Kim HT Chung, Exp Mol Med 2007 39 267 77 17603281
20. p53-dependent stimulation of redox-related genes in the lymphoid organs of gamma-irradiated - mice identification of Haeme-oxygenase 1 as a direct p53 target gene. A Meiller S Alvarez P Drané C Lallemand B Blanchard M Tovey E May, Nucleic Acids Res 2007 35 6924 34
21. Inhibition of vascular smooth muscle cell proliferation by chronic hemin treatment. T Chang L Wu R Wang, Am J Physiol Heart Circ Physiol 2008 295 H999 H1007
22. Superoxide production and expression of nox family proteins in human atherosclerosis. D Sorescu D Weiss B Lassegue RE Clempus K Szocs GP Sorescu L Valppu MT Quinn JD Lambeth JD Vega WR Taylor KK Griendling, Circulation 2002 105 1429 1435
23. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. MA O'Reilly RJ Staversky RH Watkins CK Reed KL de Mesy Jensen JN Finkelstein PC Keng, Am J Respir Cell Mol Biol 2001 24 703 710 11415935
24. The nitroxide tempol induces oxidative stress, p21(WAF1/CIP1), and cell death in HL60 cells. MB Gariboldi V Rimoldi R Supino E Favini E Monti, Free Radic Biol Med 2000 29 633 641
25. Quantification of atherosclerosis in mice. A Daugherty SC Whitman, Methods Mol Biol 2003 209 293 309 12357958
26. CD36 and atherosclerosis. R Silverstein M Febbraio, Curr Opin Lipidol 2000 11 483 491
27. CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. AC Nicholson M Febbraio J Han RL Silverstein DP Hajjar, Ann N Y Acad Sci 2000 902 128 31
28. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. EA Podrez M Febbraio N Sheibani D Schmitt RL Silverstein DP Hajjar PA Cohen WA Frazier HF Hoff SL Hazen, J Clin Invest 2000 105 1095 1108
29. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. CA Argmann CH Van Den Diepstraten CG Sawyez JY Edwards RA Hegele BM Wolfe MW Huff, Arterioscler Thromb Vasc Biol. 2001 12 12 2011 2018
30. Heme oxygenase: recent advances in understanding its regulation and role. KK Elbirt HL Bonkovsky, Proc Assoc Am Physicians 1999 111 438 447 10519165
31. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. MD Maines, FASEB J 1988 2 10 557 2268
32. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? RC Siow H Sato GE Mann, Cardiovasc Res 1999 41 385 394
33. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. K Ishikawa D Sugawara J Goto Y Watanabe K Kawamura M Shiomi H Itabe Y Maruyama, Circulation 2001 104 1831 1836
34. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. SH Juan TS Lee KW Tseng JY Liou SK Shyue KK Wu LY Chau, Circulation. 2001 104 13 1519 1525 10.1161/hc3801.095663 11571246
35. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. K Ishikawa D Sugawara Xp Wang K Suzuki H Itabe Y Maruyama AJ Lusis, Circ Res 2001 88 506 512
36. An inflammatory pathway of IFN-gamma production in coronary atherosclerosis. H Ranjbaran SI Sokol A Gallo RE Eid AO Iakimov A D'Alessio JR Kapoor S Akhtar CJ Howes M Aslan S Pfau JS Pober G Tellides, J Immunol 2007 178 592 604
37. -/-mice. SC Whitman P Ravisankar H Elam A Daugherty, Am J Pathol 2000 157 1819 1824
38. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. S Gupta AM Pablo X Jiang N Wang AR Tall C Schindler, J Clin Invest 1997 99 2752 2761
39. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. A Raisanen-Sokolowski T Glysing-Jensen J Koglin ME Russell, Am J Pathol 1998 152 359 365 9466561 (Pubitemid 28106381)
40. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. SA Schreyer JJ Peschon RC LeBoeuf, J Biol Chem 1996 271 26174 26178
41. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. W Palinski JL Witztum, J Intern Med 2000 247 371 380
42. T lymphocytes from human atherosclerotic plaques recognize oxidized low-density lipoprotein. S Stemme B Faber J Holm O Wiklund JL Witztum GK Hansson, Proc Natl Acad Sci USA 1995 92 3893 3897
43. Expression of peroxisome proliferator-activated receptor subtypes in human atherosclerosis. S Sueyoshi T Yamada M Niihasi Y Kusumi T Oinuma M Esumi K Tsuru S Imai N Nemoto I Sakura M Mitsumata, Ann N Y Acad Sci 2001 947 429 432
44. Inhibition of smooth muscle cell migration by the p21 cdk inhibitor. R Fukui N Shibata E Kobbayashi M Amakawa D Furutama M Hoshiga N Neogoro T Nakakaouji M Li T Ishihara N Ohsawa, Atherosclerosis 1997 11 53 59
45. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. MW Chang E Barr MM Lu K Barton JM Leiden, J Clin Invest 1995 96 2260 2268
46. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. ZY Yang RD Simari ND Perkins H San D Gordon GJ Nabel EG Nabel, Proc Natl Acad Sci USA 1996 93 7905 7910
47. A novel role for the cyclin-dependent kinase inhibitor p27 (Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. RC Braun-Dullaeus MJ Mann A Ziegler HE von der Leyen VJ Dzau, J Clin Invest 1999 104 815 823
48. In vitro and in vivo transfection of p21 gene enhances Cyclosporine mediated inhibition of lymphocyte proliferation. AK Khanna JD Hosenpud, J Immunol. 2000 165 4 1882 1888 10925268
49. Reciprocal role of cyclins and cyclin kinase inhibitor p21WAF1/CIP1 on lymphocyte proliferation, allo-immune activation and inflammation. AK Khanna, BMC Immunol 2005 6 22 30
50. Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. E Stabile YF Zhou M Saji M Castagna M Shou TD Kinnaird R Baffour MD Ringel SE Epstein S Fuchs, Circ Res 2003 93 1059 1065
51. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle. G Brooks XM Yu Y Wang MJ Crabbe MJ Shattock JV Harper, J Pharm Pharmacol 2003 55 519 526
52. Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathway. M Sata A Takahashi K Tanaka M Washida N Ishizaka J Ako M Yoshizumi Y Ouchi T Taniguchi Y Hirata M Yokoyama R Nagai K Walsh, Arterioscler Thromb Vasc Biol 2002 22 1305 1309
53. Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells. TJ Nathe J Deou B Walsh B Bourns AW Clowes G Daum, Arterioscler Thromb Vasc Biol 2002 22 1293 1238
54. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. G Condorelli JK Aycock G Frati C Napoli, FASEB J 2001 15 2162 2170
55. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. S Hayashi R Morishita H Matsushita H Nakagami Y Taniyama T Nakamura M Aoki K Yamamoto J Higaki T Ogihara, Hypertension. 2000 35 1 Pt 2 237 243
56. Recombinant p21 protein inhibits lymphocyte proliferation and transcription factors. AK Khanna M Plummer V Nilakantan GM Pieper, J Immunol 2005 174 7610 7617
57. A mimic of p21WAF1/CIP1 ameliorates murine lupus. C Goulvestre C Chereau C Nicco L Mouthon B Weill F Batteux, J Immunol 2005 175 6959 6967
58. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. AJ Merched L Chan, Circulation 2004 110 3830 3841
59. A cell-cycle independent role for p21 in regulating synovial fibroblast migration in rheumatoid arthritis. JM Woods K Klosowska DJ Spoden NG Stumbo DJ Paige JC Scatizzi MV Volin MS Rao H Perlman, Arthritis Res Ther 2006 8 R113 120